Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
3
×
cancer drugs
clinical trials
life sciences
national blog main
san francisco blog main
ipo
national top stories
revolution medicines
san francisco
san francisco top stories
sanofi
the column group
third rock ventures
warp drive bio
amgen
black diamond therapeutics
bladder cancer
blueprint medicines
cobimetinib
colorectal cancer
deals
deciphera pharmaceuticals
eli lilly
endometral cancer
europe blog main
european society for medical oncology
fda
glioblastoma
investing
loxo oncology
mark goldsmith
mirati therapeutics
new enterprise associates
non-small cell lung cancer
pancreatic cancer
ras
What
cancer
3
×
ipo
3
×
medicines
research
3
×
drug
proteins
revolution
targets
biotech
black
cancer’s
clinic
companies
despite
diamond
disease
eluded
family
frontiers
hardest
hit
hopes
hottest
hunters
known
lead
leading
lines
maps
molecular
nears
new
parlance
pharmaceutical
phase
play
ras
reach
ready
reels
Language
unset
Current search:
cancer
×
cancer
×
research
×
ipo
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic